CN109430664A - 一种强芯肽固体饮料 - Google Patents
一种强芯肽固体饮料 Download PDFInfo
- Publication number
- CN109430664A CN109430664A CN201810985674.XA CN201810985674A CN109430664A CN 109430664 A CN109430664 A CN 109430664A CN 201810985674 A CN201810985674 A CN 201810985674A CN 109430664 A CN109430664 A CN 109430664A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- oligofructose
- ribose
- solid beverage
- royal jelly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 20
- 235000013361 beverage Nutrition 0.000 title claims abstract description 18
- 239000007787 solid Substances 0.000 title claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 30
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 29
- 229940109850 royal jelly Drugs 0.000 claims abstract description 19
- 241000208340 Araliaceae Species 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- 241001494479 Pecora Species 0.000 claims abstract description 16
- 239000005862 Whey Substances 0.000 claims abstract description 16
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 16
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 16
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims abstract description 15
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 claims abstract description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 14
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 14
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 14
- 239000011718 vitamin C Substances 0.000 claims abstract description 14
- 238000004806 packaging method and process Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 8
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- 235000015097 nutrients Nutrition 0.000 abstract description 5
- 229910052742 iron Inorganic materials 0.000 abstract description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 229960003284 iron Drugs 0.000 abstract description 3
- 239000011664 nicotinic acid Substances 0.000 abstract description 3
- 229960003512 nicotinic acid Drugs 0.000 abstract description 3
- 235000001968 nicotinic acid Nutrition 0.000 abstract description 3
- 229910052711 selenium Inorganic materials 0.000 abstract description 3
- 239000011669 selenium Substances 0.000 abstract description 3
- 229940091258 selenium supplement Drugs 0.000 abstract description 3
- 235000019155 vitamin A Nutrition 0.000 abstract description 3
- 239000011719 vitamin A Substances 0.000 abstract description 3
- 229940045997 vitamin a Drugs 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 12
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical group COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 3
- 239000009810 qiangxin Substances 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960000980 entecavir Drugs 0.000 description 2
- YXPVEXCTPGULBZ-WQYNNSOESA-N entecavir hydrate Chemical compound O.C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)C1=C YXPVEXCTPGULBZ-WQYNNSOESA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101710142246 External core antigen Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- FLDFNEBHEXLZRX-DLQNOBSRSA-N Nystose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(O[C@@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FLDFNEBHEXLZRX-DLQNOBSRSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- -1 carbon monosaccharide Chemical class 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- FLDFNEBHEXLZRX-UHFFFAOYSA-N nystose Natural products OC1C(O)C(CO)OC1(CO)OCC1(OCC2(OC3C(C(O)C(O)C(CO)O3)O)C(C(O)C(CO)O2)O)C(O)C(O)C(CO)O1 FLDFNEBHEXLZRX-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种固体饮料，具体的说涉及一种强身健体功能的功能性食品。本发明的技术方案是：一种强芯肽固体饮料，单位剂量的包装中，含有：羊心肽粉0.6‑1.5g，D‑核糖1‑2g，低聚果糖0.1‑0.4g，乳清蛋白粉0.5‑1.5g，人参粉0.4‑1.0g，维生素C 0.1‑0.3g，蜂王浆冻干粉0.1‑0.5g。通过几种组分的合理调配，本发明提供了一种具有维生素A、铁、烟酸、硒、多种氨基酸等营养元素饮品，经常饮用，具有调节人体内的各种营养元素平衡，补充人体元气，增强人体免疫力等功能。
Description
技术领域：
本发明涉及一种固体饮料，具体的说涉及一种强身健体功能的功能性食品。
背景技术：
现代人的生活已经演变成节奏快，压力大，精神高度紧张的状态。由于交通、通信等现代交通工具的普及，人们生活节奏加快，社会竞争激烈，上班族的工作问题，学生的学业压力等都会给相应人群带来烦躁焦虑的消极情绪，使之所承受的心理压力也越来越大。同时，这些人群的饮食趋于简单，导致营养的不均衡。而在一些经济发达地区，生活水平高，物质生活富裕，长期的坐卧、以车代步等等行为使之缺乏了最基本的运动。同样学生、写字楼、密集型加工企业的上班族一般都是长期静坐、低头弯腰的姿势，长期下去，很容易出现各种健康问题，如供血不足、神经衰弱、失眠、肌肉软弱无力、肠胃功能不足等，如果不加以控制，长久下去，将增加高血压、冠心病、恶性肿瘤等疾病的发病几率。
因此，如何养成健康的生活方式是人们迫不及待的要解决的一大问题。同时，改善以上人群的营养结构，提供一种多营养成分的功能性食品，是现代人十分渴盼的事情。
发明内容
发明目的：本发明针对现代人快捷的生活方式，提供一种多营养成分的强芯肽固体饮料。
技术方案：
经过反复研究和测试，申请人提供了一种含有多种营养成分的强芯肽固体饮料。
本发明的技术方案是：一种强芯肽固体饮料，单位剂量的包装中，含有羊心肽粉0.6-1.5g，D-核糖1-2g，低聚果糖0.1-0.4g，乳清蛋白粉0.5-1.5g，人参粉0.4-1.0g，维生素C0.1-0.3g，蜂王浆冻干粉0.1-0.5g。
优选的，一种强芯肽固体饮料，单位剂量的包装中，含有羊心肽粉0.9-1.3g，D-核糖1.4-1.8g，低聚果糖0.16-0.35g，乳清蛋白粉0.8-1.2g，人参粉0.5-0.8g，维生素C0.15-0.26g，蜂王浆冻干粉0.16-0.4g。
优选的，一种强芯肽固体饮料，单位剂量的包装中，含有羊心肽粉1.0g，D-核糖1.5g，低聚果糖0.25g，乳清蛋白粉0.9g，人参粉0.6g，维生素C0.18g，蜂王浆冻干粉0.25g。
本发明所述强芯肽固体饮料的制备方法，按以下方法制备：
第一步市售羊心肽粉、D-核糖、低聚果糖、乳清蛋白粉、人参粉、维生素C、蜂王浆冻干粉分别过80目筛；
第二步称取处方量的羊心肽粉、D-核糖、低聚果糖、乳清蛋白粉、人参粉、维生素C、蜂王浆冻干粉混合均匀，分装，得本发明产品。
本发明产品建议的服用方式为每日1-2次，每次1袋，加温开水60ml，搅拌均匀即可食用。以早晨起床或临睡前服用。
本发明技术方案中：
羊心肽粉：以牛、羊心脏为原料，经过低温干燥、破碎、灭菌、生物酶解、提纯、浓缩、离心喷雾干燥而制成的高活性小分子肽粉。
心肌肽粉富含细分子活性肽、维生素A、铁、烟酸、硒等营养元素，具有养心、解郁、安神，缓解心气郁结、心悸、失眠、气短、劳心膈痛者，对心脏具有保护功能；有助于改善心肌炎、心肌缺血、冠心病、心脏病等症状。
心肌肽营养丰富，其中的氨基酸营养均衡，且易消化吸收，是食品和保健品的理想添加剂。对于消化能力差的病人、老人、儿童都很适合。
D-核糖：是重要的五碳单糖，是生物体内遗传物质――核糖核酸(RNA)的重要组成物质，在核苷类物质、蛋白质、脂肪代谢中处于枢纽位置。D-核糖作为生物体内存在于所有细胞中的天然成份，与腺苷酸的形成和三磷酸腺苷(ATP)的再生有密切关系，是生命代谢最基本的能量来源之一，在心脏和骨络肌代谢中起关键作用，能够促进局部缺血组织、局部缺氧组织的恢复。
低聚果糖又称蔗果低聚糖，是由1～3个果糖基通过β(2—1)糖苷键与蔗糖中的果糖基结合生成的蔗果三糖、蔗果四糖和蔗果五糖等的混合物。
低聚果糖是一种天然活性物质。甜度为蔗糖的0.3-0.6倍。既保持了蔗糖的纯正甜味性质，又比蔗糖甜味清爽。低聚果糖具有调节肠道菌群，增殖双歧杆菌，促进钙的吸收，调节血脂，免疫调节，抗龋齿等保健功能。最引人注目的生理特性是它能明显改善肠道内微生物种群比例，它是肠内双歧杆菌的活化增殖因子，可减少和抑制肠内腐败物质的产生，抑制有害细菌的生长，调节肠道内平衡；能促进微量元素铁、钙的吸收与利用，以防止骨质疏松症；可减少肝脏毒素，能在肠中生成抗癌的有机酸，有显著的防癌功能；且口味纯正香甜可口，具有类似脂肪的香味和爽口的滑腻感。近几年低聚果糖的产品风靡日、欧、美等保健品市场。
乳清蛋白粉：从牛奶中分离提取出来的珍贵蛋白质。乳清蛋白不但容易消化，而且还具有高生物价、高效化率、高蛋白质功效比和高利用率，是蛋白质中的精品。乳清蛋白粉含有人体所需的所有必需氨基酸，其氨基酸组成模式与骨骼肌中的氨基酸组成模式几乎完全一致，极其容易被人体所吸收。具有以下功能：提供身体构造新组织所需的氨基酸，延缓人体衰老；在体内制造酶，改善肠胃功能；·为免疫系统制造对抗细菌和感染的抗体；调节体内的水分、电解质平衡，增强机体抗疲劳能力；向细胞输送氧和各种营养物质，加速机体修复。适用于健身健美爱好者、运动员、需美容者、身体瘦弱者、极易疲劳者、孕妇及哺乳期妈妈、生长发育期的少年儿童、手术康复者、贫血、高血压及其它慢性病人以及素食者。
人参：在中国，人参历来被视为百草之王。在西方，人参叫做PANAXC.A.MEYERGINSENG，“PANAX”来源于希腊语，意思是“包治百病”。人参可以大补元气，复脉固脱，补脾益肺，生津，安神。主治：体虚欲脱，肢冷脉微，脾虚食少，肺虚喘咳，津伤口渴，内热消渴，久病虚羸，惊悸失眠，阳痿宫冷；心力衰竭，心原性休克。用于气短喘促，心悸健忘，口渴多汗，食少无力，一切急慢性疾病及失血后引起的休克、虚脱。大补元气，固脱生津，安神。治劳伤虚损，食少，倦怠，反胃吐食，大便滑泄，虚咳喘促，自汗暴脱，惊悸，健忘，眩晕头痛，阳痿，尿频，消渴，妇女崩漏，小儿慢惊，及久虚不复，一切气血津液不足之证。
维生素C又称抗坏血酸，具有减压、增强免疫力、抗癌的作用。
蜂王浆冻干粉：经真空低温干燥出来的蜂王浆粉，很好的保留了蜂王浆的营养成分。具有以下功能：一是降低血糖功能，实验证明，每天10克蜂王浆有治疗糖尿病的作用；二是抗氧化功能；三是降低血脂功能；四是控制血管扩张、降低血压功能；五是保护肝脏功能；蜂王浆不仅能够杀灭肝炎病毒，并且能抑制病毒在肝脏细胞内复制。蜂胶中的黄酮类等物质有降低转氨酶作用，促进肝细胞再生，防止肝硬变；六是抗菌、消炎功能。蜂王浆有抗菌和对伤口感染具有促进愈合的作用。试验也表明，蜂王浆的抗菌谱为大肠杆菌、金黄色葡萄球伤寒杆菌、链球菌、变形杆菌、枯草杆菌、结核杆菌、星状发癣菌和表皮癣菌等；七是抗衰老作用，和强化性功能作用，同时还有抗辐射，增强记忆力的作用。
有益效果：本发明技术方案中，通过几种组分的合理调配，为人体提供了一种具有维生素A、铁、烟酸、硒、多种氨基酸等营养元素饮品，经常饮用具有调节人体内的各种营养元素平衡，补充人体元气，增强人体免疫力，平衡人体的血脂、血糖，增加胃动力，保护肝脏，增强记忆等功能。
实施例1.羊心肽粉600g，D-核糖2000g，低聚果糖100g，乳清蛋白粉1500g，人参粉400g，维生素C100g，蜂王浆冻干粉100g。按说明书技术方案所述制备方法制备1000包强芯肽固体饮料。
实施例2.羊心肽粉1500g，D-核糖1000g，低聚果糖400g，乳清蛋白粉500g，人参粉1000g，维生素C300g，蜂王浆冻干粉500g。按说明书技术方案所述制备方法制备1000包强芯肽固体饮料。
实施例3.羊心肽粉1000g，D-核糖1500g，低聚果糖250g，乳清蛋白粉900g，人参粉600g，维生素C180g，蜂王浆冻干粉250g。按说明书技术方案所述制备方法制备1000包强芯肽固体饮料。
试验例1.医院门诊收治轻度高血压伴轻度高血脂患者160名，随机分为4组，1-3组分别服用本发明实施例1-3的产品，每日2次，每次一包，早晚服用，4组服用抗高血压药物硝苯地平片，每次10mg，1日3次。连续服用3月，第三月末的最后一周，分别每日晨起测量血压，服用实施例1-3产品和硝苯地平组的患者，血压都维持在正常范围内；且服用实施例1-3产品的患者血脂恢复到正常值范围，这些患者自述身体比以前有劲了，面色红润，说话声音洪亮；而硝苯地平组血脂基本没有变化，人的精气神也没有明显的变化。试验期间，服用实施例1-3产品的患者感冒发生率明显低于服用硝苯地平的患者。
试验例2.写字楼工作人员收集自述眼睛干涩、胃脘发胀，失眠，部分人员感觉气短，无力，容易疲劳，一天下来，无精打采，回家做饭的力气都没有了，且容易感冒的人员90名，随机分为3组，分别服用本发明实施例产品1-3，每日早或晚服用一次，每次1包。连续服用2个月，第二月末，所有人的状态都发生了明显的变化，眼睛干涩、胃脘发胀，失眠等症状全部消失，人体抵抗力也提高了，几乎没有感冒发生，且普遍反映人有劲了，愿意做家务了，工作效率也有了很大的提高。70％的人员主动索取本发明产品，表示继续服用。
试验例3.门诊收治乙肝大三阳患者120名，随机分为四组，每组30人，1组正常服用抗肝炎恩替卡韦药物，2-4组在服用抗肝炎药物恩替卡韦的基础上，加服实施例1-3产品，每日1次，每次1包。第4周末，抽血化验各项指标，2-4组患者指标全部恢复正常人指标，而1组有8名患者仍需要继续服用抗肝炎药治疗。
Claims (4)
1.一种强芯肽固体饮料，其特征在于，单位剂量的包装中，含有羊心肽粉0.6-1.5g，D-核糖1-2g，低聚果糖0.1-0.4g，乳清蛋白粉0.5-1.5g，人参粉0.4-1.0g，维生素C0.1-0.3g，蜂王浆冻干粉0.1-0.5g。
2.根据权利要求1所述强芯肽固体饮料，其特征在于，单位剂量的包装中，含有羊心肽粉0.9-1.3g，D-核糖1.4-1.8g，低聚果糖0.16-0.35g，乳清蛋白粉0.8-1.2g，人参粉0.5-0.8g，维生素C0.15-0.26g，蜂王浆冻干粉0.16-0.4g。
3.根据权利要求1所述强芯肽固体饮料，其特征在于，单位剂量的包装中，含有羊心肽粉1.0g，D-核糖1.5g，低聚果糖0.25g，乳清蛋白粉0.9g，人参粉0.6g，维生素C0.18g，蜂王浆冻干粉0.25g。
4.权利要求1所述强芯肽固体饮料的制备方法，其特征在于，包括以下步骤：
第一步市售羊心肽粉、D-核糖、低聚果糖、乳清蛋白粉、人参粉、维生素C、蜂王浆冻干粉分别过80目筛；
第二步称取处方量的羊心肽粉、D-核糖、低聚果糖、乳清蛋白粉、人参粉、维生素C、蜂王浆冻干粉混合均匀，分装，得本发明产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810985674.XA CN109430664A (zh) | 2018-08-28 | 2018-08-28 | 一种强芯肽固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810985674.XA CN109430664A (zh) | 2018-08-28 | 2018-08-28 | 一种强芯肽固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109430664A true CN109430664A (zh) | 2019-03-08 |
Family
ID=65532861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810985674.XA Pending CN109430664A (zh) | 2018-08-28 | 2018-08-28 | 一种强芯肽固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109430664A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111616374A (zh) * | 2020-07-23 | 2020-09-04 | 西咸新区优恩生物科技股份有限公司 | 一种提高及调节运动员和宇航员身体机能的营养素 |
| CN114431412A (zh) * | 2021-12-28 | 2022-05-06 | 法尔玛国际健康管理有限公司 | 一种安全高效溶解血栓和脂质斑块的营养组合物 |
| CN115381013A (zh) * | 2021-05-24 | 2022-11-25 | 陕西罗麻丹医药有限公司 | 一种能够营养心肌细胞的固体饮料及其制备方法 |
-
2018
- 2018-08-28 CN CN201810985674.XA patent/CN109430664A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111616374A (zh) * | 2020-07-23 | 2020-09-04 | 西咸新区优恩生物科技股份有限公司 | 一种提高及调节运动员和宇航员身体机能的营养素 |
| CN115381013A (zh) * | 2021-05-24 | 2022-11-25 | 陕西罗麻丹医药有限公司 | 一种能够营养心肌细胞的固体饮料及其制备方法 |
| CN114431412A (zh) * | 2021-12-28 | 2022-05-06 | 法尔玛国际健康管理有限公司 | 一种安全高效溶解血栓和脂质斑块的营养组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101248900B (zh) | 一种新型固体运动饮料冲剂 | |
| CN110338402A (zh) | 一种复合益生菌粉及其制备方法 | |
| TWI721248B (zh) | 提高耐力表現之抗疲勞組合物 | |
| CN102987379A (zh) | 一种含枸杞、菊花、胶原蛋白、柠檬、水苏糖的组合物 | |
| CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
| CN102511869A (zh) | 红枣生姜浓浆 | |
| CN101579126A (zh) | 产后及人流术后康复用特膳营养食品 | |
| CN102552625A (zh) | 一种抗衰老益智中药及其制备方法 | |
| CN104738624A (zh) | 一种神经衰弱、健忘失眠的营养保健食品 | |
| CN109430664A (zh) | 一种强芯肽固体饮料 | |
| CN101669624B (zh) | 一种具有改善妇女贫血功能的中药八宝茶及其制备方法 | |
| CN106418545A (zh) | 一种营养均衡的功能性食品 | |
| CN103156108A (zh) | 一种防治糖尿病高血压病症的强化食品 | |
| CN105233140A (zh) | 一种短梗五加健脾益胃功能的组合物及其制备方法 | |
| CN104839698A (zh) | 心血管疾病非全营养配方食品 | |
| CN104621556A (zh) | 一种具有耐缺氧和抗疲劳功能的组合物及其应用 | |
| CN104855978A (zh) | 抗衰老非全营养配方食品 | |
| CN105380073A (zh) | 一种糖尿病营养餐冲剂 | |
| CN108066712A (zh) | 一种补气养血中药组合物 | |
| CN104855963A (zh) | 产妇产后调理非全营养配方食品 | |
| CN104855972A (zh) | 妇女延更调理非全营养配方食品 | |
| CN107648512A (zh) | 一种改善人体微循环的中药组合物及制备方法 | |
| CN101675800B (zh) | 一种妇女产后滋补膏及制备方法 | |
| CN103238713B (zh) | 一种养益心脏的食品养生茶冲剂 | |
| CN104839699A (zh) | 心脏病非全营养配方食品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190308 |
|
| WD01 | Invention patent application deemed withdrawn after publication |